Clinical Trial Update: QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for QL1706 in combination with short-course radiotherapy and chemotherapy for mismatch repair-proficient, non-metastatic rectal cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mismatch Repair-proficient Rectal Cancer
• Rectal Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced Rectal Cancer (LARC), Mismatch Repair-Proficient (pMMR) Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING